Infusible platelet membrane as a platelet substitute for transfusion: an overview.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

10 citing papers in PubMed.

1. Biosynthetic blood surrogates: Current status and future opportunities.Bioengineering & translational medicine · 2025
   Review
2. Artificial blood-hope and the challenges to combat tumor hypoxia for anti-cancer therapy.Medical & biological engineering & computing · 2025
   Review
3. Platelet-inspired nanomedicine in hemostasis thrombosis and thromboinflammation.Journal of thrombosis and haemostasis : JTH · 2022
   Review
4. Bioinspired artificial platelets: past, present and future.Platelets · 2022
   Review
5. Platelet Transfusion-Insights from Current Practice to Future Development.Journal of clinical medicine · 2021
   Review
6. On the Quest for In Vitro Platelet Production by Re-Tailoring the Concepts of Megakaryocyte Differentiation.Medicina (Kaunas, Lithuania) · 2020
   Review
7. Bioinspired artificial platelets for transfusion applications in traumatic hemorrhage.Transfusion · 2020
   Review
8. Intravenous synthetic platelet (SynthoPlate) nanoconstructs reduce bleeding and improve 'golden hour' survival in a porcine model of traumatic arterial hemorrhage.Scientific reports · 2018
   Article
9. Targeted repair of heart injury by stem cells fused with platelet nanovesicles.Nature biomedical engineering · 2018
   Article
10. Biomaterials and Advanced Technologies for Hemostatic Management of Bleeding.Advanced materials (Deerfield Beach, Fla.) · 2018
    Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as